Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients
Author:
Funder
National Natural Science Foundation of China
National Science and Technology Support Program
973 project
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/article/10.1007/s10549-018-4673-6/fulltext.html
Reference47 articles.
1. Bartek J, Falck J, Lukas J (2001) CHK2 kinase–a busy messenger. Nat Rev Mol Cell Biol 2(12):877–886. https://doi.org/10.1038/35103059
2. Bartek J, Lukas J (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3(5):421–429
3. Antoni L, Sodha N, Collins I et al (2007) CHK2 kinase: cancer susceptibility and cancer therapy—two sides of the same coin? Nat Rev Cancer 7(12):925–936. https://doi.org/10.1038/nrc2251
4. Cybulski C, Wokolorczyk D, Jakubowska A et al (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J Clin Oncol 29(28):3747–3752. https://doi.org/10.1200/jco.2010.34.0778
5. Weischer M, Bojesen SE, Ellervik C et al (2008) CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J Clin Oncol 26(4):542–548. https://doi.org/10.1200/jco.2007.12.5922
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Low-Penetrance Susceptibility Variants in Colorectal Cancer—Current Outlook in the Field;International Journal of Molecular Sciences;2024-07-30
2. Identification of <b><i>CHEK2</i></b> Germline Mutations in <b><i>BRCA1/2-</i></b> and <b><i>PALB2</i></b>-Negative Breast and Ovarian Cancer Patients;Human Heredity;2022
3. Association between 15 known or potential breast cancer susceptibility genes and breast cancer risks in Chinese women;Cancer Biology and Medicine;2021
4. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate;Cells;2020-12-12
5. Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk;Annals of Translational Medicine;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3